T-Therapeutics

Advancing TCR bispecific therapies for cancer and autoimmune disorders.
Advancing TCR bispecific therapies for cancer and autoimmune disorders.

Sector

Life Sciences

Category

Therapeutics

Location

Cambridge, UK

Initial Investment

2023
T-Therapeutics

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge. The company was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.